NCT05654025 Follow up Study on Visual Prognosis and Complications of Ectopia Lentis Lens
| NCT ID | NCT05654025 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University |
| Condition | Ectopia Lentis |
| Study Type | OBSERVATIONAL |
| Enrollment | 604 participants |
| Start Date | 2022-12-05 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 604 participants in total. It began in 2022-12-05 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-centre, observational cohort study with the following objectives: Firstly, the investigators aim to evaluate the vision-related quality of life and mental health status in congenital ectopia lentis patients. Secondly, the investigators target to investigate the correlations between genotype and clinical phenotype in patients of congenital ectopia lentis. Thirdly, to explore the metabolic profiles in the aqueous humor (AH) of patients with congenital ectopia lentis. Lastly, this study aims to explore the longitudinal changes of ocular biological parameters and complications in patients with postoperative congenital ectopia lens in the Chinese population.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with congenital lens dislocation and age ≥ 3 years old. * Agree to participate in this study with written informed consent from patients or legal guardians. Exclusion Criteria: * History of ophthalmic trauma or other ophthalmic surgeries. * Combined with other ophthalmic diseases such as primary glaucoma, uveitis and corneal disease. * Patients who could not cooperate in the examinations.
Contact & Investigator
Danying Zheng
PRINCIPAL INVESTIGATOR
Guangdong Provincial Clinical Research Center for Ocular Diseases
Frequently Asked Questions
Who can join the NCT05654025 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, studying Ectopia Lentis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05654025 currently recruiting?
Yes, NCT05654025 is actively recruiting participants. Contact the research team at zhengdyy@163.com for enrollment information.
Where is the NCT05654025 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT05654025 clinical trial?
NCT05654025 is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. The principal investigator is Danying Zheng at Guangdong Provincial Clinical Research Center for Ocular Diseases. The trial plans to enroll 604 participants.